
Greenbrook TMS Inc
TSX:GTMS

Gross Margin
Greenbrook TMS Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
CA |
![]() |
Greenbrook TMS Inc
TSX:GTMS
|
28.6m CAD |
48%
|
|
US |
![]() |
CVS Health Corp
NYSE:CVS
|
97.4B USD |
14%
|
|
US |
C
|
Cigna Group
XMUN:CGN
|
69.4B EUR |
10%
|
|
US |
![]() |
Cigna Corp
NYSE:CI
|
81.9B USD |
10%
|
|
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
27.2B EUR |
25%
|
|
DE |
![]() |
Fresenius SE & Co KGaA
XETRA:FRE
|
26.8B EUR |
25%
|
|
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
23.1B USD |
28%
|
|
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
20.1B USD |
33%
|
|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.6B EUR |
25%
|
|
US |
![]() |
Hims & Hers Health Inc
NYSE:HIMS
|
13.1B USD |
76%
|
|
US |
![]() |
DaVita Inc
NYSE:DVA
|
9.5B USD |
33%
|
Greenbrook TMS Inc
Glance View
Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company is headquartered in Toronto, Ontario and currently employs 430 full-time employees. The company went IPO on 2018-10-03. The TMS therapy is a non-invasive therapy for the treatment of depressive disorder (MDD) and other mental health disorders. The TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. The firm's patient-focused, customer service model provides TMS therapy accessible to all patients through three business processes: Patient Inquiry; Patient Conversion; and Treatment Delivery. A course of TMS consists of 36 treatments and a course of treatment consist of an initial cortical mapping and motor threshold determination and treatment, daily treatment sessions and a subsequent motor threshold re-determination and treatment. The company operates through approximately 130 Company-operated treatment centers. The company operates across the States of North Carolina, South Carolina, Maryland, Delaware, Missouri, Illinois, and Ohio.

See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Greenbrook TMS Inc's most recent financial statements, the company has Gross Margin of 47.6%.